Literature DB >> 18182821

Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.

Imad Uthman1, Ali Taher, Ossama Abbas, Janine Menassa, Samer Ghosn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18182821     DOI： 10.1159/000112938

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  5 in total

1.  The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Authors:  Khaled M Musallam; Thurayya Arayssi; Ali T Taher; Nadim Kanj; Imad Uthman
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

2.  Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.

Authors:  R R Winkelmann; Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-01

3.  Rituximab in severe skin diseases: target, disease, and dose.

Authors:  Daniel D Bennett; Maro Ohanian; Christian T Cable
Journal:  Clin Pharmacol       Date:  2010-07-07

4.  Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus.

Authors:  Mariana Álvares Penha; Ricardo da Silva Libório; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

Review 5.  Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Authors:  S C Hofmann; M J Leandro; S D Morris; D A Isenberg
Journal:  Lupus       Date:  2013-08       Impact factor: 2.911
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.